We have investigated the genetic origin of autoantibody production 
Introduction
Systemic lupus erythematosus and related chronic inflammatory disorders in humans and mice are closely associated with, and possibly mediated by, circulating immune complexes that deposit in various organs and cause tissue damage and disease. At least part of the antibodies involved in immune complex formation react with DNA and other self-antigens, which has led to the notion that these diseases are autoimmune in nature. Cell transfer studies in murine model systems have further suggested that the underlying defect resides within the immune This study was presented in part at the Annual Meeting ofthe Federation of American Societies for Experimental Biology, 2 April 1987, system. However, in spite ofintensive investigations (reviewed in reference 1), the exact cellular and molecular abnormalities leading to B cell hyperactivity and autoantibody production are still unknown. As suggested by the occurrence of similar antibodies in normal individuals (2, 3) , the autoantibodies expressed in these diseases may be normal components of the immune system that become pathogenic when expressed at high levels and for extended lengths of time, possibly because of defective immune regulatory circuits, potent polyclonal or antigenic stimulation, or insufficient immune complex removal. Alternatively, disease-associated autoantibodies may differ from those found in normal subjects and result from abnormalities in the complex mechanisms generating antibody diversity (reviewed in references 4 and 5) , including abnormal Ig germline genes, defective selection of variable (V)1 and diversity (D) gene segments during generation of the preimmune repertoire, or defects in somatic antibody diversification. These not necessarily exclusive possibilities can be distinguished by analyzing the genetic origin of disease-associated autoantibodies. Such studies also address the primary structure of autoantibodies, their clonal derivation, and the contribution of somatic events to their diversification as well as provide information about inducing agents, the developmental stage at which B cells acquire self-specificity, and the structural relatedness among such antibodies.
Corresponding studies have been initiated in murine lupus models and have provided considerable insights into the genetic origin ofautoantibodies (reviewed in references 6 and 7). Thus, the Ig heavy chain variable region gene complex (Igh-V) ofautoimmune mice investigated thus far appeared normal by restriction fragment length polymorphism (RFLP) criteria, and the disease is not associated with a particular Igh-Vhaplotype (8) (9) (10) . However, possible associations with Ig K light chain variable region gene complex (Igk-V) haplotypes or with abnormalities in the V, germline gene repertoire remain to be determined. The gene segments encoding the autoantibodies that typify lupus mice (anti-DNA, anti-Ig [rheumatoid factor, RF], antihistone) have also been investigated. Our nucleic acid sequence analyses revealed that such molecules may be encoded by a variety of V, D, and J (joining) gene segments, most of which were closely related to those found in antibodies to exogenous antigens (1 1, 12) . Although these findings argued against abnormalities in the generation ofautoantibodies, they provided only limited information about the individual antiself response characteristics, since only a single prototype was analyzed for each of the above specificities. Recently, genetic restriction has been reported for antibromelaine-treated red 1 . Abbreviations used in this paper: C, constant; D, diversity; Igh-V, Ig heavy chain variable region gene complex; Igk-V, Ig K light chain variable region gene complex; J, joining; RF, rheumatoid factor; blood cell antibodies (13) and for RF from nonautoimmune (14) and lupus mice (15) , although results with regard to the latter type of autoantibodies are controversial (16) . Somewhat restricted VH gene usage has also been suggested by Ig gene rearrangement analysis of anti-DNA-producing hybridomas (17) , however, only a small number of murine anti-DNA nucleic acid sequences have been reported ( 1, 18, 19 ) and more information regarding the genetic origin of this important anti-self response is clearly needed.
The present study describes the organization of the Igk-V gene complex in lupus mice and defines gene segments encoding sev ral lupus-associated anti-DNA autoantibodies. Using RFLP analysis, we determined the Igk-V haplotypes of all major' ipus strains and showed that lupus disease is not associated vith a particular Igk-V haplotype, and that abnormalities in the VK germline gene repertoire do not appear to be a prerec aisite for autoantibody production and disease development. Subsequently, the gene segments encoding monoclonal anti-)14A heavy and light chains from MRL-lpr/lpr and (NZI X W)F1 lupus mice were determined by cDNA cloning and iucleic acid sequence analysis. The six monoclonals (five anal ized in this study and one previously) were (22) , VJ0 (23) , V, 12-13 (24) , and Vl9 (25) have been described. A genomic subclone containing the entire T1 5 V./JJ5 (26) and MPC 167 VJJ,,5 (27) I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I   I  I   I  I   I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I   I  I  I  I  I  I  I  I   I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I   I  I  I   I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I E-4 family (40) . For the BXW-DNA16 V, gene, only a 88% match was found in the data base (a V,,9 gene encoding an anti-[anti-(Glu' Ala30 Tyr"0), antibody [41] ). Hence, with the possible exception of BXW-DNA 16, all anti-DNAs expressed V,, genes that encode responses to exogenous antigens as well.
MRL-DNA4 and MRL-DNA22 J, segments differed from the BALB/c germline J,2 and JK4 germline sequences (42) in three and two positions, respectively. The same differences were observed in other MRL-lpr/lpr J, segments previously (8, 43), and are probably allelic. The Jsl and JX2 segments expressed in BXW-DNA14 and BXW-DNA 16, respectively, were identical to the corresponding BALB/c germline gene segments. Heavy chain genes. All VH genes, except that of MRL-DNA4, revealed around or over 90% similarity to VH genes of the large J558 family: the MRL-DNA22 VH gene was identical to that of MRL-DNA10 and showed over 94% match with VH sequences encoding antibodies to the hapten nitrophenyl (44, 45) . The VH genes encoding the (NZB X W)F1 anti-DNAs 7, 14, and 16 had their closest matches in germline genes VH23 (89% [44] ) and VH105 (92% [46] (47) , although in two reading frames, which resulted in quite different amino acid sequences. The J segments in MRL-DNA22 (JH4), (JH3), BXW-DNA14 (JH2) were identical to the corresponding BALB/c germline sequences (48) whereas the BXW-DNA16 JH2 segment showed a single silent nucleotide difference in codon 104. The BXW-DNA7 JH1 segment differed in two nucleotides (codon 101 and 111) from the corresponding BALB/c germline sequence. These differences may be either allotypic or secondary to somatic mutation.
Discussion
In this study, we address possible associations of murine lupus with abnormalities in the genes and complex mechanisms generating antibody diversity and analyze genetic and structural requirements for anti-DNA reactivity. We first investigated whether autoantibody production and lupus disease are associated with particular Ig haplotypes or abnormal Ig germline genes. Previous studies have not identified disease associations with any particular Igh-Vhaplotype, and the VH genes of lupus mice appeared normal by RFLP criteria (8) (9) (10) . This conclusion also appeared to be true for the new VH gene family (28) defined by MRL-DNA4, an anti-DNA autoantibody analyzed in this study (data not shown). Since the Igk-Vcomplex is also polymorphic (35) , we tested various lupus and nonautoimmune control strains for RFLPs with VX DNA probes corresponding to 12 VX groups (40) . These (18) could be assigned to known D gene families (47) . Of interest, the length of the third complementarity-determining region, which is considered important for antigen and antiidiotype recognition, differed from 7-14 residues. All anti-DNA V genes published thus far (1 1, 18, 19, this report), originated from existing VH or VK gene families except that encoding the MRL-DNA4 H chain. However, corresponding VH genes are present in the germline of normal mice as well, and have been observed in hybridoma antibodies of unknown specificity from lipopolysaccharide-stimulated C57BL/6 splenocytes (Dildrop, R., personal communication). Close similarity, or even identity, was observed with V genes expressed in response to exogenous antigens, indicating that the same V genes can be used to encode autoantibodies and antibodies to exogenous antigens.
A question ofconsiderable interest is that ofgenetic restriction among autoantibodies. While the overall lupus-associated anti-self response appears essentially unrestricted (6) , there is increasing evidence for genetic restriction among autoantibodies with a given specificity (13) (14) (15) , a finding also seen in exogenous responses. Our results and data from the literature suggest that the degree of restriction of the anti-DNA response is low: seven of eight murine anti-DNA VH nucleic acid sequences published thus far (the nearly identical VH sequences encoding four clonally related hybridomas from reference 19 are here considered as one) probably originated from independent germline genes since they differed from each other in 25 to over 50 nucleotides. The six anti-DNA V, genes known to date (five from this report and one encoding four clonally related anti-DNAs [19] ) belonged to V, groups 1, 2, 4, 5, and 9. Moreover, evidence for involvement of additional VH and V, families in anti-DNA antibodies has been presented in the literature, including Q52, 7183, S107, VK8, VJl9, V,21 (6) .
Hence, the variety of V genes that fulfill the structural requirements of participation in DNA-binding site generation is remarkable. Human monoclonal anti-DNAs can also be encoded by dissimilar VH genes (50) , although such antibodies may be genetically more restricted in humans than in mice (51) . The genetic diversity of anti-DNA autoantibodies agrees with the serologic observation that anti-DNA antibodies recognize a considerable number of different epitopes (31) . Additional possibilities may be that many combinations ofdifferent V genes can generate similar binding sites, or that quite dissimilar binding sites (with possible additional binding capacities) react with DNA. Clearly, resolving these important issues will require three-dimensional structure analysis of corresponding immune complexes. 
